This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Gastroschisis복벽파열증

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q79.3 (gastroschisis) | Special Copayment Reduction: V155
B. SynonymsGastroschisis, abdominal wall cleft, Congenital laparoschisis, congenital abdominal wall defect
C. Adult onsetLikelihood of first onset in adulthood: very low — can be diagnosed immediately by visual inspection at birth, and there are no cases in which diagnosis is delayed until adulthood. Most cases are detected in fetal life by prenatal ultrasound.
1. History1943: first described by Bernstein. 1981: silo method introduced by Schuster and Binnington. Since the 2000s: spread of immediate primary closure (bedside closure). Incidence is increasing worldwide.
2. CausesAbnormal vascular development of the abdominal wall to the right of the umbilicus (involution of the right umbilical vein or rupture of a right embryonic vessel). Young maternal age (< 20 years), use of NSAIDs or aspirin, smoking and undernutrition are risk factors. Mostly sporadic.
3. GeneticsMostly sporadic. Associated chromosomal abnormalities are much lower (about 1–3%) than in omphalocele (10–15%). Familial occurrence is rare. Recurrence risk about 3–4%.
4. General epidemiologyAbout 1 in 3,333–5,000 births. Incidence increasing worldwide. Higher frequency in young mothers. Survival rate of isolated gastroschisis about 90% or higher.
5. PathophysiologyRupture of abdominal wall vessels to the right of the umbilicus → direct exposure of bowel without a covering membrane → bowel inflammation caused by amniotic fluid (matting, edema, fibrin coating) → bowel dysmotility → reduced absorptive function.
6. SymptomsDirect exposure of bowel without a covering membrane through a 2–3cm defect to the right of the umbilicus. Bowel edema, inflammation and fibrin coating. Bowel stenosis and obstruction (complex gastroschisis). Risk of short bowel syndrome.
7. SignsAt birth: 2–3cm defect to the right of the umbilicus, direct exposure of bowel without a covering membrane, edema, inflammation and fibrin coating of the bowel surface. Prenatal ultrasound: defect to the right of the umbilicus, free-floating bowel loops in the amniotic fluid.
8. ScreeningPrenatal ultrasound (12–20 weeks of gestation). Elevated MSAFP (80–100%). More intensive surveillance in young pregnant women (< 20 years).
9. DiagnosisPrenatal ultrasound: defect to the right of the umbilicus, free-floating bowel loops in the amniotic fluid, no covering membrane. After birth: immediate confirmation by clinical findings. Differentiation from omphalocele (presence of a covering membrane, location).
10. TreatmentImmediate bowel protection (saline gauze, transparent dressing). Simple type: immediate primary closure (bedside reduction) or staged silo correction. Complex type (bowel stenosis or obstruction): additional bowel resection and anastomosis. Establishing enteral nutrition is the key.
11. PrognosisSurvival rate of simple type >90%. Complex type (including short bowel syndrome): poor. Establishing enteral nutrition takes 2–8 weeks. Long-term complications: nutritional disorders, growth retardation, gastroesophageal reflux. Long-term prognosis generally good.
12. PreventionAvoidance of NSAIDs and aspirin during pregnancy in young pregnant women. Smoking cessation. Early prenatal ultrasound screening. Planned delivery at a specialized tertiary hospital. Folic acid intake.
13. ReferencesLap CCMM et al. systematic review (2016), Ledbetter DJ (2006) … and 9 other papers

1. History

The history of gastroschisis began relatively recently. The term 'Gastroschisis' derives from the Greek gaster (stomach, belly) + schisis (cleft, splitting), meaning a state in which the abdominal wall is split. The origin of the term is somewhat controversial, but in modern medicine, the first clear description of gastroschisis as an independent disease distinct from omphalocele is known to be Bernstein's 1943 report. Previously, gastroschisis and omphalocele were often confused and treated as parts of the same disease.

The history of surgical treatment of gastroschisis began with the development of neonatal surgery. Initially, primary closure was attempted, but because the abdominal cavity was not sufficiently developed, abdominal compartment syndrome occurred after primary closure. In 1981, Schuster and Binnington introduced a staged correction method using a silo made of silicone material, and the method of reducing herniated bowel gradually from the silo rather than immediately into the abdominal cavity became widespread. Later, in the 2000s, the introduction of the spring-loaded silo made it possible to place a silo at the bedside in the neonatal intensive care unit, without an operating room, and to reduce the bowel gradually. In addition, the immediate primary closure technique (bedside or operative primary closure) has been re-examined, and in appropriately selected patients the method of immediately reducing the bowel and closing the abdominal wall in the neonatal intensive care unit without general anesthesia is being applied successfully.

An epidemiologically important fact is that the incidence of gastroschisis has increased significantly worldwide since the 1990s. In several countries, including the United States, the United Kingdom and Northern Europe, the incidence of gastroschisis was reported to have increased from about 0.5–1/10,000 in the 1960s–70s to 2–4.5/10,000 since the 2000s. The cause of this increase has not yet been fully elucidated, but changes in the proportion of young mothers (teens to twenties), increased use of NSAIDs/aspirin and changes in smoking patterns have been proposed as associated factors. In Korea as well, gastroschisis is registered and managed under the rare disease Special Copayment Reduction (V155), and treatment experience is accumulating at major pediatric surgery centers.

2. Causes

The cause of gastroschisis differs from that of omphalocele and is most widely accepted to be abnormal vascular development of the abdominal wall to the right of the umbilicus. Two hypotheses are currently supported. The first is the umbilical vein involution hypothesis, the theory that during early fetal development, as the right embryonic umbilical vein normally involutes, the region of the abdominal wall to the right of the umbilicus that it supplied becomes vulnerable to ischemia, resulting in a defect. The second is the hypothesis of weakened structures around the umbilical vein, the theory that during normal abdominal wall development, the peritoneal mesoderm to the right of the umbilicus forms a weak area where the abdominal wall defect occurs. Both hypotheses explain why the defect occurs predominantly to the right of the umbilicus, but which hypothesis is more valid has not yet been established.

The risk factors for gastroschisis are distinctly different from those for omphalocele. The strongest risk factor is young maternal age; the frequency of gastroschisis is markedly higher especially in mothers younger than 20 years. Numerous epidemiological studies have reported that use of NSAIDs (nonsteroidal anti-inflammatory drugs) during pregnancy, especially aspirin and ibuprofen, increases the risk of gastroschisis. A proposed mechanism is that these drugs cause constriction of fetal abdominal wall vessels or disrupt prostaglandin-mediated vascular development. Smoking is reported to increase the risk of gastroschisis about 1.5–2-fold, explained by nicotine-induced vasoconstriction promoting abdominal wall ischemia. Cocaine and other vasoconstrictive drugs have also been reported as risk factors. Nutritional deficiency, underweight mothers and early pregnancy after oral contraceptive use have also been suggested as risk factors.

Unlike omphalocele, gastroschisis has a very low association with genetic syndromes or chromosomal abnormalities. The frequency of associated anomalies is also about 10–15%, much lower than in omphalocele (50–70%), and the most common associated anomalies are mainly anomalies of the bowel itself (malrotation, intestinal atresia, intestinal stenosis). Cardiac anomalies, genitourinary anomalies and chromosomal abnormalities are rare.

3. Genetics

In contrast to omphalocele, gastroschisis has a very weak association with genetic causes. The frequency of associated chromosomal abnormalities is very low, about 1–3% of all gastroschisis cases, and no strong association with any specific genetic syndrome is known. Most gastroschisis occurs sporadically, and familial occurrence is rare. The recurrence risk in siblings is about 3–4%, slightly higher than in the general population but low in absolute terms.

Discordant occurrence of gastroschisis has been reported in monozygotic twins, suggesting that environmental factors or developmental stochasticity, rather than simple genetic determinism, play an important role in the development of gastroschisis. With respect to genetic heterogeneity, some studies have proposed the hypothesis that polymorphisms in genes related to vascular development and angiogenesis (e.g., VEGF pathway-related genes) may be associated with gastroschisis, but no established causative gene has been identified to date.

In patients with gastroschisis, prenatal genetic testing (karyotyping, CMA) is performed only when associated anomalies are present or suspected. The clinical utility of routine genetic testing in simple gastroschisis (no associated anomalies) is limited. However, the possible association between genotype and phenotype in predicting complex complications such as intestinal atresia and bowel necrosis is expected to be explored in future research. In genetic counseling, it is explained that gastroschisis is mainly associated with environmental risk factors, and because the recurrence risk is low but not negligible, intensive prenatal ultrasound in the next pregnancy is recommended.

4. General epidemiology

Gastroschisis occurs at a frequency of about 1 in 3,333–5,000 births, and it is estimated that about 10,000–20,000 neonates are affected worldwide each year. A distinctive epidemiological feature is that the incidence has been continuously increasing over the past several decades. In the United States, the incidence of gastroschisis approximately doubled between 1995 and 2005, and a similar increasing trend has been reported in Europe, including the United Kingdom. Changes in the proportion of young mothers, increased NSAID exposure and lifestyle changes have been proposed as causes of this increase, but it is difficult to explain by a single cause.

The sex distribution is nearly equal between boys and girls, with no particular sex bias. The association with maternal age is very strong; the risk of gastroschisis is reported to be 7–10 times higher in mothers aged 15–19 years than in mothers aged 35 years or older. This is the opposite pattern to omphalocele, which is more frequent in older mothers. In Korea, the incidence of gastroschisis may be somewhat lower than in Western countries (the proportion of young mothers is low due to the rising average age at marriage), but it is reported to share the overall increasing trend.

The frequency of associated anomalies in gastroschisis (about 10–15%) is markedly lower than in omphalocele (50–70%), and this is the key factor in the difference in prognosis. Most associated anomalies are anomalies of the bowel itself (malrotation, intestinal atresia, stenosis), and cardiac anomalies, genitourinary anomalies and chromosomal abnormalities are rare. Complicated gastroschisis: cases accompanied by intestinal atresia, bowel obstruction, intestinal agenesis (atresia) or bowel necrosis, accounting for about 10–15% of the total; in these cases the prognosis is markedly worse than in the simple type and the risk of short bowel syndrome is high. The survival rate of simple gastroschisis is excellent at over 90%.

5. Pathophysiology

The pathogenesis of gastroschisis consists of the formation of an abdominal wall defect due to abnormal vascular development of the abdominal wall to the right of the umbilicus, and the process by which the resulting exposed bowel suffers chemical injury from amniotic fluid. If abnormal blood supply (ischemia due to involution of the right umbilical vein) occurs during weeks 4–8 of gestation, when the abdominal wall to the right of the umbilicus is forming, abdominal wall formation in that region fails and a defect of about 2–3cm develops. Unlike omphalocele, no peritoneal–amniotic covering membrane forms over this defect, so the bowel is exposed directly to the amniotic fluid without a covering membrane.

In bowel exposed to amniotic fluid without a covering membrane, chemical bowel injury (chemical peritonitis) occurs. As pregnancy progresses, amniotic fluid becomes contaminated by fetal urine, digestive secretions and the like, increasing its chemical activity, and in bowel exposed to this amniotic fluid for a prolonged period, inflammatory reaction, edema and fibrin deposition progress. This process is called 'matting', a state in which bowel loops stick together, bowel motility decreases and the bowel wall thickens. Chemical injury of the bowel leads to dysmotility of the intestinal muscle layer and reduced absorptive function, which is why recovery of bowel function is slow even after surgery.

In complex gastroschisis, the exposed bowel may be compressed by the edges of the defect, causing bowel ischemia. This results in intestinal atresia, intestinal stenosis and bowel necrosis, in which case extensive bowel resection is required and the risk of short bowel syndrome rises sharply. Short bowel syndrome is a serious complication in which there is insufficient small bowel absorptive surface area, making it difficult to establish enteral nutrition and requiring long-term dependence on parenteral nutrition. Intestinal malrotation is also commonly associated with gastroschisis, because normal rotation did not occur during the return of the bowel into the abdominal cavity. Because the risk of midgut volvulus increases due to the unpartitioned peritoneum after the bowel returns, correction of malrotation including the Ladd procedure is performed at the same time.

6. Symptoms

The clinical presentation of gastroschisis is an obvious malformation immediately recognizable by visual inspection at birth. Immediately after birth, there is a 2–3cm (sometimes larger) abdominal wall defect to the right of the umbilicus, through which the small bowel, large bowel and sometimes the stomach are observed directly exposed without a covering membrane. The umbilicus itself is in its normal position and is separated from the defect, which lies to its right. This is the most important visual distinguishing point from omphalocele (in which the defect is at the center of the umbilicus and a covering membrane is present).

The appearance of the exposed bowel depends on the duration of amniotic fluid exposure. When fresh, the bowel surface is close to a normal pink color, but the longer the amniotic fluid exposure, the more the bowel swells (edema), its surface becomes covered with a dull green-brown fibrinous coating, and the loops stick together in a matted state. The more severe the matting, the slower the recovery of bowel function. If immediate bowel protection (saline gauze, transparent dressing) is not provided after birth, bowel desiccation, further contamination and heat loss occur.

Complex gastroschisis is accompanied by intestinal atresia, stenosis and necrosis. Intestinal atresia may not be evident immediately after birth and presents as vomiting, abdominal distension and inability to advance enteral feeding when enteral nutrition is attempted after surgery. When short bowel syndrome develops, the period of dependence on enteral nutrition becomes markedly longer, and nutritional disorders, growth retardation and liver damage (liver disease associated with long-term parenteral nutrition) occur. If there is associated malrotation, acute bowel ischemia due to midgut volvulus may occur, requiring immediate surgery. Because neonates develop severe hypothermia, hypovolemia and fluid and electrolyte losses from the exposed bowel, immediate fluid replacement and maintenance of body temperature after birth are essential.

7. Signs

The physical signs of gastroschisis are recognized by visual inspection immediately after birth. A 2–4cm abdominal wall defect to the right of the umbilicus and bowel loops exposed without a covering membrane are observed. The umbilicus is in its normal position to the left of the defect, the edges of the defect are sharp, and there are no remnants of a covering membrane. The exposed bowel may be severely edematous or have a fibrin coating, and in the complex type the bowel may darken in color or show findings of bowel ischemia or necrosis. Differentiation from omphalocele is based on the presence of a covering membrane, the location of the defect and the site of umbilical cord insertion.

On prenatal ultrasound, an abdominal wall defect to the right of the umbilicus is identified at 12–20 weeks of gestation, and free-floating bowel loops in the amniotic fluid are characteristic. Because the herniated bowel has no covering membrane, its boundary with the amniotic fluid is indistinct on ultrasound. The colon and stomach are mainly located within the abdominal cavity, and the small bowel floats in the amniotic fluid. Maternal serum alpha-fetoprotein (MSAFP) is elevated in about 80–100% of gastroschisis cases (AFP leaks directly into the amniotic fluid because there is no covering membrane) and tends to be more markedly elevated than in omphalocele. On prenatal ultrasound, blood flow in the exposed bowel is assessed by Doppler examination, and bowel ischemia due to the edges of the defect is monitored. Progression to the complex type is difficult to predict prenatally, but bowel dilatation (increased bowel diameter), loss of bowel motility and early polyhydramnios have been reported as warning signs of progression to the complex type.

8. Screening

Prenatal screening for gastroschisis is performed through standard prenatal ultrasound examinations of pregnant women. Some cases may be detected even at the NT scan at 12–14 weeks of gestation, but most are diagnosed at the anomaly scan at 18–22 weeks of gestation. If an abdominal wall defect to the right of the umbilicus and free-floating bowel loops in the amniotic fluid are identified on ultrasound, the patient is immediately referred to a maternal-fetal medicine (MFM) specialist team for detailed evaluation.

Maternal serum alpha-fetoprotein (MSAFP) testing is also useful in screening for gastroschisis. If MSAFP is elevated to 2.5 times the median or more (> 2.5 MoM), an abdominal wall defect is suspected and detailed ultrasound is performed. Because MSAFP is elevated in about 80–100% of gastroschisis cases, screening sensitivity is high. MSAFP screening is included in Korean prenatal screening tests and is performed at 15–20 weeks of gestation.

Follow-up management after prenatal diagnosis of gastroschisis monitors the bowel condition (bowel diameter, bowel motility, compression by the edges of the defect) with repeat ultrasound at 2–4 week intervals and identifies progression to the complex type early. If findings of a rapid increase in bowel diameter or loss of bowel motility are seen, early delivery may be considered. Fetal echocardiography and detailed ultrasound are performed to evaluate associated anomalies, and if the complex type is suspected, further evaluation is done with fetal MRI. Because the risk of gastroschisis is high in young mothers (especially under 20 years), more intensive prenatal ultrasound surveillance is recommended in this group.

9. Diagnosis

Prenatal diagnosis of gastroschisis is made by ultrasound, and postnatal diagnosis is confirmed immediately by clinical findings alone. The diagnosis can be made when an abdominal wall defect to the right of the umbilicus, free-floating bowel loops in the amniotic fluid and absence of a covering membrane (bowel directly exposed to amniotic fluid) are identified on prenatal ultrasound. The edges of the defect are sharp, the umbilical cord insertion is in its normal position to the left of the defect, and herniation of solid organs such as the liver and spleen is rare (a difference from omphalocele).

Postnatal diagnosis is made immediately by the direct exposure of bowel without a covering membrane to the right of the umbilicus. Clinical differentiation from omphalocele is important, and the key distinguishing points are: ① covering membrane: absent in gastroschisis, present in omphalocele; ② defect location: 2–3cm to the right of the umbilicus in gastroschisis, at the center of the umbilicus in omphalocele; ③ umbilical cord insertion: normal position to the left of the defect in gastroschisis, at the apex of the hernia sac in omphalocele; ④ herniated organs: mainly small and large bowel in gastroschisis, may include the liver and spleen in omphalocele. If intestinal atresia or stenosis is suspected, it is confirmed by exploration at surgery and contrast bowel studies. Echocardiography is performed to exclude associated cardiac anomalies, and chromosomal testing is considered only in the complex type or when associated anomalies are present.

10. Treatment

Treatment of gastroschisis begins immediately after birth. Immediately at birth, the exposed bowel is protected (saline gauze, transparent dressing or a neonatal bowel bag), hypothermia and fluid loss are prevented, and fluid replacement and stabilization of the general condition are carried out in the neonatal intensive care unit. A nasogastric tube is inserted to maintain gastric decompression, and intravenous antibiotics are administered. The timing and method of surgery are determined by the size of the defect, the condition of the bowel (simple vs. complex type) and the general condition of the neonate.

Immediate primary closure (or bedside closure) can be chosen when the defect is small and the volume of the herniated organs is sufficient for reduction into the abdominal cavity. It is a method of immediately reducing the herniated bowel into the abdominal cavity and closing the abdominal wall at the bedside in the neonatal intensive care unit, without general anesthesia in the operating room. If intra-abdominal pressure rises (intravesical pressure > 20cmH₂O), there is a risk of abdominal compartment syndrome, so monitoring is required. When immediate closure is possible with intra-abdominal pressure within an acceptable range, it has the advantage of allowing rapid bowel protection and abdominal wall correction without the risks of general anesthesia.

Staged silo correction is used when immediate primary closure is not possible (excessive volume of herniated organs, severe bowel edema). A spring-loaded silo is placed around the defect and compressed a little each day to gradually reduce the bowel into the abdominal cavity, and after complete reduction in several days to 1 week, the abdominal wall is closed in the operating room. During staged reduction, bowel edema decreases and the abdominal cavity gradually expands, so intra-abdominal pressure can be kept within a safe range at primary closure.

In complex gastroschisis (with intestinal atresia, stenosis or necrosis), resection of necrotic bowel with primary anastomosis (direct joining) or stoma formation is required. When short bowel syndrome develops, long-term parenteral nutrition (TPN), gut rehabilitation and therapy to promote intestinal growth (GLP-2 analog, teduglutide) are needed, and intestinal transplantation is considered if necessary. Malrotation is corrected with the Ladd procedure at the time of abdominal wall correction. After abdominal wall correction, enteral nutrition is established gradually according to recovery of bowel function, which usually takes 2–4 weeks in the simple type and may take several months in the complex type.

11. Prognosis

The prognosis of gastroschisis is generally among the better ones for congenital anomalies. The survival rate in simple gastroschisis is reported to be over 90%, higher than the overall survival rate of omphalocele (70–80%). This is because the frequency of serious associated anomalies (cardiac, chromosomal abnormalities) is low in gastroschisis. However, in complex gastroschisis (intestinal atresia, necrosis, short bowel syndrome), the survival rate is reduced and the long-term prognosis is poor.

The most common short-term postoperative complication is delayed establishment of enteral nutrition. In the simple type, enteral nutrition is established within an average of 2–4 weeks, but it takes longer when bowel edema is severe or in the complex type. During this period, parenteral nutrition (TPN) is maintained, and TPN-related complications (infection, liver damage) may occur. Long-term complications include ① gastroesophageal reflux (GERD): occurs due to reduced intra-abdominal volume after reduction into the abdominal cavity, sometimes requiring medication or antireflux surgery. ② Intestinal adhesions and obstruction: bowel obstruction may occur due to adhesions from previous surgery. ③ Nutritional disorders and growth retardation: particularly prominent in the complex type or short bowel syndrome. ④ Neurodevelopment: mostly normal, but neurodevelopmental delay due to prolonged hospitalization, surgery and TPN has been reported in some. In long-term follow-up studies, most survivors of simple gastroschisis are reported to maintain a normal quality of life in adulthood, without significant limitations in education, employment or social functioning.

12. Prevention

The most important strategy for preventing gastroschisis is avoiding known environmental risk factors. Numerous epidemiological studies have reported that avoiding NSAIDs (nonsteroidal anti-inflammatory drugs, e.g., aspirin, ibuprofen, naproxen) during pregnancy or when planning pregnancy may help reduce the risk of gastroschisis. When pain management is unavoidable, a physician is consulted and safe alternatives during pregnancy (acetaminophen, etc.) are used. Because smoking increases the risk of gastroschisis, smoking cessation before and during pregnancy is recommended. Use of vasoconstrictive drugs such as cocaine is avoided.

Because the risk of gastroschisis is high in young mothers (especially under 20 years), intensive prenatal ultrasound surveillance from early pregnancy is recommended in this group. Evidence on whether folic acid intake during pregnancy is effective in preventing gastroschisis has not yet been established, but because folic acid helps prevent several congenital anomalies, intake is recommended from 3 months before pregnancy through early pregnancy.

When prenatal diagnosis has been made, planned delivery at a tertiary medical institution with specialized pediatric surgery, neonatology and neonatal intensive care teams allows optimal treatment to begin immediately at birth and can improve the prognosis. There is currently no clear evidence of a difference in prognosis according to mode of delivery (vaginal delivery vs. cesarean section), so it is determined by obstetric indications. If progression to complex gastroschisis is suspected (increased bowel diameter or loss of bowel motility on prenatal ultrasound), immediate delivery at a tertiary hospital and preparation of the pediatric surgery team should be arranged. If a previous child was born with gastroschisis, intensive prenatal surveillance is performed in the next pregnancy, considering the recurrence risk (about 3–4%).

13. References

  1. Ledbetter DJ. Gastroschisis and omphalocele. Surg Clin North Am. 2006;86(2):249-260. DOI: 10.1016/j.suc.2005.12.003. PMID: 16580930.

  2. Lap CCMM, Brizot ML, Pistorius LR, et al. Outcome of isolated fetal gastroschisis: a systematic review and meta-analysis. Eur J Pediatr Surg. 2016;26(5):393-401. DOI: 10.1055/s-0036-1584153. PMID: 27303931.

  3. Salemi JL, Pierre M, Tanner JP, et al. Temporal trends in the prevalence of congenital anomalies associated with gastroschisis. Pediatrics. 2016;138(1):e20160126. DOI: 10.1542/peds.2016-0126. PMID: 27329002.

  4. Baerg J, Kaban G, Tonita J, Pahwa P, Reid D. Gastroschisis: a sixteen-year review. J Pediatr Surg. 2003;38(5):771-774. DOI: 10.1016/jpsu.2003.50179. PMID: 12720193.

  5. Overcash RT, DeUgarte DA, Stephenson ML, et al. Factors associated with gastroschisis outcomes. Obstet Gynecol. 2014;124(3):551-557. DOI: 10.1097/AOG.0000000000000425. PMID: 25126922.

  6. Segel SY, Marder SJ, Parry S, Macones GA. Fetal abdominal wall defects and mode of delivery: a systematic review. Obstet Gynecol. 2001;98(5 Pt 1):867-873. DOI: 10.1016/s0029-7844(01)01521-1. PMID: 11704185.

  7. Hidaka N, Tsukimori K, Hojo S, et al. Correlation between ultrasound bowel findings and perinatal outcome in prenatally diagnosed gastroschisis. J Perinat Med. 2009;37(5):553-558. DOI: 10.1515/JPM.2009.090. PMID: 19604087.

  8. Christison-Lagay ER, Kelleher CM, Langer JC. Neonatal abdominal wall defects. Semin Fetal Neonatal Med. 2011;16(3):164-172. DOI: 10.1016/j.siny.2011.02.009. PMID: 21454143.

  9. Brandt ML. Pediatric hernias. Surg Clin North Am. 2008;88(1):27-43. DOI: 10.1016/j.suc.2007.10.003. PMID: 18267160.

  10. Abdel-Latif ME, Bolisetty S, Abeywardana S, Lui K. Mode of delivery and neonatal survival of infants with gastroschisis in Australia and New Zealand. J Pediatr Surg. 2008;43(9):1685-1690. DOI: 10.1016/j.jpedsurg.2008.02.071. PMID: 18778999.